270 related articles for article (PubMed ID: 18001077)
1. Design of a tumor-homing cell-penetrating peptide.
Myrberg H; Zhang L; Mäe M; Langel U
Bioconjug Chem; 2008 Jan; 19(1):70-5. PubMed ID: 18001077
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of cell-penetrating peptides for cargo delivery.
Pooga M; Langel U
Methods Mol Biol; 2005; 298():77-89. PubMed ID: 16044541
[TBL] [Abstract][Full Text] [Related]
4. Transtumoral targeting enabled by a novel neuropilin-binding peptide.
Roth L; Agemy L; Kotamraju VR; Braun G; Teesalu T; Sugahara KN; Hamzah J; Ruoslahti E
Oncogene; 2012 Aug; 31(33):3754-63. PubMed ID: 22179825
[TBL] [Abstract][Full Text] [Related]
5. Cell-penetrating peptides as delivery vehicles for biology and medicine.
Stewart KM; Horton KL; Kelley SO
Org Biomol Chem; 2008 Jul; 6(13):2242-55. PubMed ID: 18563254
[TBL] [Abstract][Full Text] [Related]
6. Anticancer versus antigrowth activities of three analogs of the growth-inhibitory peptide: relevance to physicochemical properties.
Mizejewski GJ; Eisele L; Maccoll R
Anticancer Res; 2006; 26(4B):3071-6. PubMed ID: 16886636
[TBL] [Abstract][Full Text] [Related]
7. A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery.
Li ZJ; Wu WK; Ng SS; Yu L; Li HT; Wong CC; Wu YC; Zhang L; Ren SX; Sun XG; Chan KM; Cho CH
J Control Release; 2010 Dec; 148(3):292-302. PubMed ID: 20854857
[TBL] [Abstract][Full Text] [Related]
8. Specific peptides for the therapeutic targeting of oncogenes.
Privé GG; Melnick A
Curr Opin Genet Dev; 2006 Feb; 16(1):71-7. PubMed ID: 16377176
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance to chlorambucil in murine B-cell leukemic cells is overcome by its conjugation to a targeting peptide.
Gellerman G; Baskin S; Galia L; Gilad Y; Firer MA
Anticancer Drugs; 2013 Feb; 24(2):112-9. PubMed ID: 23187462
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer activity of targeted pro-apoptotic peptides.
Ellerby HM; Arap W; Ellerby LM; Kain R; Andrusiak R; Rio GD; Krajewski S; Lombardo CR; Rao R; Ruoslahti E; Bredesen DE; Pasqualini R
Nat Med; 1999 Sep; 5(9):1032-8. PubMed ID: 10470080
[TBL] [Abstract][Full Text] [Related]
11. Aminopeptidase P Mediated Targeting for Breast Tissue Specific Conjugate Delivery.
Cordova A; Woodrick J; Grindrod S; Zhang L; Saygideger-Kont Y; Wang K; DeVito S; Daniele SG; Paige M; Brown ML
Bioconjug Chem; 2016 Sep; 27(9):1981-90. PubMed ID: 26965452
[TBL] [Abstract][Full Text] [Related]
12. Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties.
Soler M; González-Bártulos M; Soriano-Castell D; Ribas X; Costas M; Tebar F; Massaguer A; Feliu L; Planas M
Org Biomol Chem; 2014 Mar; 12(10):1652-63. PubMed ID: 24480922
[TBL] [Abstract][Full Text] [Related]
13. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
[TBL] [Abstract][Full Text] [Related]
14. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
[TBL] [Abstract][Full Text] [Related]
15. Cellular delivery of peptide nucleic acid by cell-penetrating peptides.
Kilk K; Langel U
Methods Mol Biol; 2005; 298():131-41. PubMed ID: 16044544
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of doxorubicin-peptide conjugate with multidrug resistant tumor cell killing activity.
Liang JF; Yang VC
Bioorg Med Chem Lett; 2005 Nov; 15(22):5071-5. PubMed ID: 16168650
[TBL] [Abstract][Full Text] [Related]
17. Cell-specific delivery of a chemotherapeutic to lung cancer cells.
Zhou X; Chang YC; Oyama T; McGuire MJ; Brown KC
J Am Chem Soc; 2004 Dec; 126(48):15656-7. PubMed ID: 15571383
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel antitumor peptide based on the screening of an Ala-library derived from the LALF(32-51) region.
Vallespi MG; Fernandez JR; Torrens I; Garcia I; Garay H; Mendoza O; Granadillo M; Falcon V; Acevedo B; Ubieta R; Guillen GE; Reyes O
J Pept Sci; 2010 Jan; 16(1):40-7. PubMed ID: 19908203
[TBL] [Abstract][Full Text] [Related]
19. Dendrimer display of tumor-homing peptides.
Lempens EH; Merkx M; Tirrell M; Meijer EW
Bioconjug Chem; 2011 Mar; 22(3):397-405. PubMed ID: 21261269
[TBL] [Abstract][Full Text] [Related]
20. Protein delivery by the cell-penetrating peptide YTA2.
Myrberg H; Lindgren M; Langel U
Bioconjug Chem; 2007; 18(1):170-4. PubMed ID: 17226970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
